Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.731
-0.009 (-1.22%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $27.87 million as of July 22, 2024. Its market cap has decreased by -47.71% in one year.
Market Cap
27.87M
Enterprise Value
-45.68M
1-Year Change
-47.71%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $27.87M, a decrease of -95.96%. That is a compound annual growth rate of -60.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 27.90M | -34.35% |
| Dec 29, 2023 | 42.50M | -13.27% |
| Dec 30, 2022 | 49.00M | -73.18% |
| Dec 31, 2021 | 182.70M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 29.07M |
| Surrozen | 28.79M |
| bioAffinity Technologies | 28.56M |
| Enlivex Therapeutics | 28.28M |
| Palatin Technologies | 27.92M |
| RenovoRx | 27.78M |
| Brainstorm Cell Therapeutics | 27.56M |
| Acasti Pharma | 26.69M |